Testicular cancer: Optimal management of stage I seminoma in 2015

@article{Toner2015TesticularCO,
  title={Testicular cancer: Optimal management of stage I seminoma in 2015},
  author={G. Toner},
  journal={Nature Reviews Urology},
  year={2015},
  volume={12},
  pages={249-251}
}
  • G. Toner
  • Published 2015
  • Medicine
  • Nature Reviews Urology
  • Despite its excellent prognosis, optimal management of stage I seminoma remains controversial, with variations in expert opinion and international guidelines, particularly in terms of uncertainty regarding long-term treatment complications. Recent population-based reports shed new light on the subject, and help clarify the important, unresolved clinical questions that require further research to answer. 
    1 Citations

    Topics from this paper.

    References

    SHOWING 1-10 OF 12 REFERENCES
    Optimal management of clinical stage I testis cancer: one size does not fit all.
    • R. de Wit, G. Bosl
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2013
    • 23
    Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.
    • 89
    Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    • 46
    Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).
    • R. Oliver, G. Mead, +6 authors S. Stenning
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2011
    • 219
    Second cancers among 40,576 testicular cancer patients: focus on long-term survivors.
    • 652
    • PDF
    Active surveillance is the preferred approach to clinical stage I testicular cancer.
    • 103